Literature DB >> 11250672

Do we now have a relevant animal model for breast cancer?

B Gusterson, B Howard, T Crook, B Tennent.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 11250672      PMCID： PMC138500          DOI： 10.1186/bcr2

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN： 1465-5411            Impact factor:   6.466


× No keyword cloud information.
  11 in total

1.  Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.

Authors:  P D Smith; S Crossland; G Parker; P Osin; L Brooks; J Waller; E Philp; M R Crompton; B A Gusterson; M J Allday; T Crook
Journal:  Oncogene       Date:  1999-04-15       Impact factor: 9.867

2.  Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

Authors:  M Tirkkonen; O Johannsson; B A Agnarsson; H Olsson; S Ingvarsson; R Karhu; M Tanner; J Isola; R B Barkardottir; A Borg; O P Kallioniemi
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

3.  Inducible gene targeting in mice.

Authors:  R Kühn; F Schwenk; M Aguet; K Rajewsky
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

4.  Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.

Authors:  R T Cormier; K H Hong; R B Halberg; T L Hawkins; P Richardson; R Mulherkar; W F Dove; E S Lander
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

5.  Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.

Authors:  M A Webster; J N Hutchinson; M J Rauh; S K Muthuswamy; M Anton; C G Tortorice; R D Cardiff; F L Graham; J A Hassell; W J Muller
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

6.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

Authors:  S R Lakhani; J Jacquemier; J P Sloane; B A Gusterson; T J Anderson; M J van de Vijver; L M Farid; D Venter; A Antoniou; A Storfer-Isser; E Smyth; C M Steel; N Haites; R J Scott; D Goldgar; S Neuhausen; P A Daly; W Ormiston; R McManus; S Scherneck; B A Ponder; D Ford; J Peto; D Stoppa-Lyonnet; Y J Bignon; J P Struewing; N K Spurr; D T Bishop; J G Klijn; P Devilee; C J Cornelisse; C Lasset; G Lenoir; R B Barkardottir; V Egilsson; U Hamann; J Chang-Claude; H Sobol; B Weber; M R Stratton; D F Easton
Journal:  J Natl Cancer Inst       Date:  1998-08-05       Impact factor: 13.506

7.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

8.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

Authors:  X Xu; K U Wagner; D Larson; Z Weaver; C Li; T Ried; L Hennighausen; A Wynshaw-Boris; C X Deng
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

9.  Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo.

Authors:  J A Drebin; V C Link; M I Greene
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

Review 10.  MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.